Real-World Impact of Pharmacogenomics and Comprehensive Medication Management Case Study

Answering the call for real-world data on the clinical and economic outcomes of pharmacogenomics (PGx) and comprehensive medication management (CMM), Coriell Life Sciences (CLS) – an international leader in precision medicine – has released new research on the impact of these tools at scale.

Molecular Diagnosis of Vaginitis: Comparing Quantitative PCR and Microbiome Profiling Approaches to Current Microscopy Scoring

Largest comprehensive study on diagnostic methods for infectious vaginitis.

Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry

PGx as an enhancement to the current standard of care for psychiatric patients.

Diagnosing Bacterial Vaginosis with a Novel, Clinically-Actionable Molecular Diagnostic Tool

White paper published July 18, 2018.

Pharmacogenetic guidelines and decision support tools for depression treatment

LLD PGx evidence base incorporated into existing commercial decision support tools and clinical pharmacogenetic guidelines.